A fluorescence-detection size-exclusion chromatography-based thermostability assay for membrane protein precrystallization screening.

Optimization of membrane protein stability under different solution conditions is essential for obtaining crystals that diffract to high resolution. Traditional methods that evaluate protein stability require large amounts of material and are, therefore, ill suited for medium- to high-throughput screening of membrane proteins. Here we present a rapid and efficient fluorescence-detection size-exclusion chromatography-based thermostability assay (FSEC-TS). In this method, the target protein is fused to GFP. Heated protein samples, treated with a panel of additives, are then analyzed by FSEC. FSEC-TS allows one to evaluate the thermostability of nanogram-to-microgram amounts of the target protein under a variety of conditions without purification. We applied this method to the Danio rerio P2X4 receptor and Caenorhabditis elegans GluCl to screen ligands, ions, and lipids, including newly designed cholesterol derivatives. In the case of GluCl, the screening results were used to obtain crystals of the receptor in the presence of lipids.

[1]  Harini Krishnamurthy,et al.  X-ray structures of LeuT in substrate-free outward-open and apo inward-open states , 2012, Nature.

[2]  R. Neutze,et al.  Membrane protein crystallization from lipidic phases. , 2009, Current opinion in structural biology.

[3]  S. Rasmussen,et al.  Structure of a nanobody-stabilized active state of the β2 adrenoceptor , 2010, Nature.

[4]  B. Khakh,et al.  ATP-gated P2X cation-channels , 2009, Neuropharmacology.

[5]  N. Karpowich,et al.  Simple screening method for improving membrane protein thermostability. , 2011, Methods.

[6]  R. Stevens,et al.  Microscale fluorescent thermal stability assay for membrane proteins. , 2008, Structure.

[7]  W. Ward,et al.  Renaturation of Aequorea green-fluorescent protein , 1981 .

[8]  Brian K. Kobilka,et al.  High resolution crystal structure of human B2-adrenergic G protein-coupled receptor. , 2007 .

[9]  E. Gouaux,et al.  Crystal structure of the ATP-gated P2X4 ion channel in the closed state , 2009, Nature.

[10]  M. Hattori,et al.  Molecular mechanism of ATP binding and ion channel activation in P2X receptors , 2012, Nature.

[11]  Cheng Zhang,et al.  Structure and Function of an Irreversible Agonist-β2 Adrenoceptor complex , 2010, Nature.

[12]  A. Sands,et al.  Knockouts model the 100 best-selling drugs—will they model the next 100? , 2003, Nature Reviews Drug Discovery.

[13]  G. Burnstock,et al.  Modulation of ATP‐responses at recombinant rP2X4 receptors by extracellular pH and zinc , 1999, British journal of pharmacology.

[14]  R. North,et al.  Signaling at purinergic P2X receptors. , 2009, Annual review of physiology.

[15]  D. Vassilatis,et al.  Cloning of an avermectin-sensitive glutamate-gated chloride channel from Caenorhabditis elegans , 1994, Nature.

[16]  F. Markwardt,et al.  Block by extracellular Mg2+ of single human purinergic P2X4 receptor channels expressed in human embryonic kidney cells , 2000, Neuroscience Letters.

[17]  W. Ward,et al.  Renaturation of Aequorea gree-fluorescent protein. , 1981, Biochemical and biophysical research communications.

[18]  Eric Gouaux,et al.  Structure of acid-sensing ion channel 1 at 1.9 A resolution and low pH. , 2007, Nature.

[19]  M. J. Lemieux,et al.  Three‐dimensional crystallization of the Escherichia coli glycerol‐3‐phosphate transporter: A member of the major facilitator superfamily , 2003, Protein science : a publication of the Protein Society.

[20]  Eric Gouaux,et al.  Crystal structure of a bacterial homologue of Na+/Cl--dependent neurotransmitter transporters , 2005, Nature.

[21]  W. Stühmer,et al.  Characterization of recombinant human P2X4 receptor reveals pharmacological differences to the rat homologue. , 1997, Molecular pharmacology.

[22]  C. Lluis,et al.  Adenosine A2A receptor-antagonist/dopamine D2 receptor-agonist bivalent ligands as pharmacological tools to detect A2A-D2 receptor heteromers. , 2009, Journal of medicinal chemistry.

[23]  Eric Gouaux,et al.  Principles of activation and permeation in an anion-selective Cys-loop receptor , 2011, Nature.

[24]  Da-Neng Wang,et al.  Identification and characterization of a bacterial hydrosulphide ion channel , 2012, Nature.

[25]  R. Stevens,et al.  High-Resolution Crystal Structure of an Engineered Human β2-Adrenergic G Protein–Coupled Receptor , 2007, Science.

[26]  R. North.  Molecular physiology of P2X receptors. , 2002, Physiological reviews.

[27]  P. Séguéla,et al.  Phosphoinositides Regulate P2X4 ATP-Gated Channels through Direct Interactions , 2008, The Journal of Neuroscience.

[28]  Eric Gouaux,et al.  Fluorescence-detection size-exclusion chromatography for precrystallization screening of integral membrane proteins. , 2006, Structure.

[29]  H. Lester,et al.  The structural basis of function in Cys-loop receptors , 2010, Quarterly Reviews of Biophysics.

[30]  E. Gouaux,et al.  X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor , 2009, Nature.

[31]  O. Nureki,et al.  Crystal structure of the MgtE Mg2+ transporter , 2007, Nature.

[32]  Janet L. Smith,et al.  A defined protein–detergent–lipid complex for crystallization of integral membrane proteins: The cytochrome b6f complex of oxygenic photosynthesis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[33]  W. Ward.  PROPERTIES OF THE COELENTERATE GREEN-FLUORESCENT PROTEINS , 1981 .

[34]  L. Guan,et al.  Manipulating phospholipids for crystallization of membrane transport proteins , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[35]  E. Gouaux,et al.  Structure and Mechanism of a Na+-Independent Amino Acid Transporter , 2009, Science.